Gotschlich, Liu, and Artenstein (4) and Weiss and Long (10) have described methods for producing group-specific high-molecular-weight polysaccharide antigens from the supernatant culture fluids of Neisseria meningitidis groups A and C. These investigators have, however, encountered difficulties in growing the organisms in the medium of Watson and Scherp (9) in volumes larger than 1 to 1.5 liters. Thus, the preparation of large volumes of culture filtrates for producing purified polysaccharides would be especially cumbersome in that it would require the processing of a considerable number of individual 2-or 4-liter filasks. In a more recent publication, Robinson and Apicella (7) reported producing meningococcal culture filtrates in 5-liter volumes, growing the organisms in a fermentor. However, the medium used was that of Mueller-Hinton.
Of all of the methods for the preparation of purified meningococcal polysaccharides described by various investigators (5, 7, 9, 10) , only that of Gotschlich et al. (4) resulted in a product having demonstrable immunogenicity and protective properties in man (1) . Consequently, this study sought to devise practical methods for producing and purifying the group A and C polysaccharides in larger quantities without deviating from the strains, the medium, and the basic processing procedures that have yielded effective products. Analytical methods. Protein determinations on the meningococcal preparations were performed by the method of Lowry et al. (6) by using bovine serum albumin as a standard. Nucleic acid content was determined by the ultraviolet absorbancy at 260 nm by using E1 cmO.% of 20.0. The method of Fiske and SubbaRow (2) was used for the determination of phosphorus for the "A" polysaccharides. The sialic acid content of the "C" polysaccharides was determined by the method of Svennerholm (8) , with a sample of the C polysaccharide used by Gotschlich, Goldschneider, and Artenstein (3) for trials in humans serving as a standard. Molecular size was estimated by gel filtration on Sephadex G-200 (Pharmacia Fine Chemicals, Inc., Piscataway, N.J.), as described by Gotschlich, Liu, and Artenstein (4) .
MATERIALS
Toxicity. The presence of biologically active endotoxin was determined, as described by Gotschlich and co-workers (3), by measuring the pyrogenic response of rabbits to a 2.5-,Ag dose (injected intravenously) of purified polysaccharide.
RESULTS
Preparation of the medium. In preliminary studies, it became apparent that the medium of Watson and Scherp (9) press. The sterile filtrate was then dispensed in 100-and 1,000-ml amounts and stored at 22 C. A second solution was prepared consisting of 5.25 g of Na2HPO4.7H20 per liter and 3.3 mg of phenol red per liter. For seed broth, 1.1 liters of this second solution was dispensed per 4-liter flask, and, for the production bottle, 9.8 liters was dispensed per 20-liter carboy. These preparations were sterilized by autoclaving at 121 C for 75 min. In addition, 4 ml of UCON Lubricant (LB-625; Union Carbide Corp.) was added to 50 ml of distilled water and sterilized by autoclaving at 121 C for 60 min.
Before use, the 100-ml volume of the Casamino Acids-dextrose-salt solution was added to the 1.1 liters of seed solution, and the 1 ,000-ml volume of the Casamino Acids-dextrose-salt solution, together with the UCON solution, was added to the 20-liter carboy. The final pH of the medium was 7.3 to 7.4. The bottles of the final medium were incubated at 36 C for 48 to 72 hr before inoculation, to check for contamination which may have occurred during the transfer process.
Inoculation and growth of the organism. The procedure described by Gotschlich et , the resulting precipitates were collected by centrifugation (in a Sharples supercentrifuge), and the "wet" crude polysaccharide was obtained by the method described by Gotschlich et al. (4) . At this point, a series of steps, which included (i) converting the "wet" crude material to dryness, (ii) redissolving the dry material, and (iii) centrifuging the crude solution twice at 100,000 x g, was eliminated. Analysis of fluid materials for polysaccharide content after the subsequent homogenization procedure with and without the above steps indicated that, in terms of yield, there was no advantage to their inclusion. It was also found that a significant amount of polysaccharide could be extracted from the emulsions formed during the homogenization procedure [this step was used by Watson and Scherp (9) in their method for preparing purified meningococcal polysaccharides], and, although these materials were relatively high in protein and nucleic acid content, these contaminants were readily removed in the subsequent purification steps. Accordingly, the "wet" material was dissolved in 100 ml of distilled water and was processed through four to five cycles of homogenization with chloroform (30 min/cycle) to remove the bulk of the contaminating protein and nucleic acid from the aqueous material. The chloroform emulsions formed at each cycle were pooled and extracted twice with 50 ml of distilled water, and the extracts were homogenized once more with chloroform. The clear supernatant obtained after centrifugation was added to the first aqueous material. The aqueous pools were then treated with either 3 volumes of ethanol to precipitate the C polysaccharide or 10 volumes to precipitate the A polysaccharide. The precipitates were collected by centrifugation and were redissolved in 100 ml of distilled water. Final purification was then attained [to bring the protein, nucleic acid, and endotoxin content of the final purified polysaccharides to the levels found in the standard preparations (3)1 by first adding 2 Table 1 .
When assayed in this laboratory, the purified polysaccharides prepared by the methods of Gotschlich et al. showed a molecular weight of over 100,000; a sialic acid content of at least 85% for the C polysaccharide; a phosphorus content of at least 7.0% for the A polysaccharide; and protein and nucleic acid contents each below 1 %7.
Therefore, by these criteria, the final products obtained in this study were considered equivalent to the preparations of Gotschlich et al.
In addition, data obtained from M. S. Artenstein (personal communication) indicated that the purified group A and C materials prepared by the methods described in this study performed in in vitro systems and the C materials performed in man, similarly to the polysaccharides prepared by Gotschlich et al.
DISCUSSION
The results of these studies indicate that group A and C purified polysaccharides can be produced on a pilot-scale level by using the medium and essentially the methods described by Gotschlich and co-workers (4). Although some modifications were made to simplify and shorten the procedure, no new reagents were introduced.
Although the yield of Sharples sediment after Cetavlon precipitation of the A preparation was twice that of the C, this was not reflected in the amount of crude precipitate or in yield of final product which, in both instances, were approximately the same. At the crude precipitate step, there appeared to be approximately twice as much contaminating protein and nucleic acid in the A preparation than in the C, but the five repeated treatments with chloroform appeared to remove these contaminants more efficiently from the A material. The A product at this point had approximately the same nucleic acid content but considerably lower protein than the C preparation. With both preparations, the amount of polysaccharide extracted from the chloroform emulsions added considerably to the final product yield, and, although the level of contaminants with the polysaccharides available in the extract pools was increased, the three subsequent alcohol and centrifuge treatments reduced the protein and nucleic acid contents of the final purified product to a satisfactory level.
Both the A and C purified antigens were found, by Sephadex G-200 gel filtration, to have molecular weights exceeding 100,000, and 2.5 ,g of either material injected intravenously into rabbits did not cause any perceptible pyrogenic response.
The yields of purified A and C polysaccharides obtained from 36-liter cultures (16 mg/liter) were approximately twice those reported by Gotschlich et al. (4) , obtained from 1-to 1.5-liter cultures (A = 8.6 mg/liter; C = 9 mg/liter), and were comparable in per cent protein, nucleic acid, sialic acid, phosphorus, molecular weight, and freedom from endotoxin to those preparations of A and C polysaccharides used in humans (1, 3) . Thus, a single pilot run yielded a total of 576 mg of purified polysaccharide or the equivalent of 11,500 human immunizing doses (50 Mig each).
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